Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease

Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology

(2013) Huating Li et al.   Frontiers of Medicine

Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults

(2012) Ryuichi Kawamoto et al.   Cardiovascular Diabetology

Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?

(2012) Marina Shargorodsky et al.   Cardiovascular Diabetology

Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques

(2012) So-Yeon An et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21

(2012) Pedro Iglesias et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Relationship of Serum Fibroblast Growth Factor 21 with Abnormal Glucose Metabolism and Insulin Resistance: The Baltimore Longitudinal Study of Aging

(2012) Richard D. Semba et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis

(2012) Thomas Reinehr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China

(2012) Huating Li et al.   JOURNAL OF HEPATOLOGY

Serum FGF-21 Levels in Type 2 Diabetic Patients

(2011) Xingbo Cheng et al.   ENDOCRINE RESEARCH

Serum fibroblast growth factor 21 levels in polycystic ovary syndrome

(2010) Suheyla Gorar et al.   GYNECOLOGICAL ENDOCRINOLOGY

Liver Fat But Not Other Adiposity Measures Influence Circulating FGF21 Levels in Healthy Young Adult Twins

(2010) Henna Tyynismaa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

(2010) Huating Li et al.   JOURNAL OF HEPATOLOGY

Serum Fibroblast Growth Factor 21 Is Associated with Adverse Lipid Profiles and γ-Glutamyltransferase But Not Insulin Sensitivity in Chinese Subjects

(2009) Huating Li et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia

(2009) Sebastian Stein et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fibroblast Growth Factor 21 Corrects Obesity in Mice

(2008) Tamer Coskun et al.   ENDOCRINOLOGY